Lv2
110 积分 2022-11-13 加入
BCMA targeting CAR T cells using a novel D-domain binder for multiple myeloma: clinical development update
15小时前
求助中
A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor
6个月前
已完结
A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies
7个月前
已完结
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
11个月前
已完结
"Bloody" good factors for keeping the brain young
1年前
已完结
Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response
1年前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1年前
已完结
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
1年前
已完结
Synapse-tuned CARs enhance immune cell anti-tumor activity
1年前
已完结
TREM1 activation of myeloid cells promotes antitumor immunity
1年前
已完结
皖公网安备34019202002308
